| P50 | author | Christian Weber | Q37838769 |
| | Andreas Schober | Q43135309 |
| | Jürgen Bernhagen | Q88059352 |
| P2860 | cites work | A proinflammatory cytokine inhibits p53 tumor suppressor activity | Q22010796 |
| | MIF signal transduction initiated by binding to CD74 | Q24303802 |
| | CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex | Q24307384 |
| | Crystal structure at 2.6-A resolution of human macrophage migration inhibitory factor | Q24605965 |
| | Active movement of T cells away from a chemokine | Q28114990 |
| | Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1 | Q28138425 |
| | Macrophage migration inhibitory factor: a regulator of innate immunity | Q28204158 |
| | MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia | Q28265011 |
| | Link between macrophage migration inhibitory factor and cellular redox regulation | Q28268442 |
| | Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury | Q28286412 |
| | MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment | Q28298072 |
| | Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response | Q28592426 |
| | Mechanisms of monocyte recruitment in vascular repair after injury | Q28648014 |
| | Inflammation, atherosclerosis, and coronary artery disease | Q29547232 |
| | Inflammation in atherosclerosis | Q29547428 |
| | The pathogenesis of atherosclerosis: a perspective for the 1990s | Q29547827 |
| | The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium | Q30308237 |
| | The expression of macrophage migration inhibitory factor 1alpha (MIF 1alpha) in human atherosclerotic plaques is induced by different proatherogenic stimuli and associated with plaque instability. | Q33209673 |
| | Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries | Q34098485 |
| | Cytokines in atherosclerosis: pathogenic and regulatory pathways | Q34511711 |
| | Novel mechanistic concepts for the control of leukocyte transmigration: specialization of integrins, chemokines, and junctional molecules | Q35052510 |
| | Up-regulated expression of the CXCR2 ligand KC/GRO-alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression. | Q35088170 |
| | The nuclear protein HMGB1, a new kind of chemokine? | Q35556137 |
| | Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease | Q35866628 |
| | The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor | Q36363184 |
| | An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction | Q36366117 |
| | The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat. | Q36377113 |
| | Inflammation and cellular immune responses in abdominal aortic aneurysms | Q36404719 |
| | SDF-1alpha-mediated tissue repair by stem cells: a promising tool in cardiovascular medicine? | Q36483554 |
| | Advances in coronary angioplasty | Q36825488 |
| | Inhibitory effects of novel AP-1 decoy oligodeoxynucleotides on vascular smooth muscle cell proliferation in vitro and neointimal formation in vivo | Q38287637 |
| | Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity | Q40169158 |
| | Stimulation of vascular smooth muscle cell migration by macrophage migration inhibitory factor | Q40382602 |
| | The intima. Soil for atherosclerosis and restenosis. | Q40463309 |
| | Macrophage migration inhibitory factor: a regulator of glucocorticoid activity with a critical role in inflammatory disease. | Q41682891 |
| | Regulation of the immune response by macrophage migration inhibitory factor: biological and structural features. | Q41735831 |
| | Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice | Q44936555 |
| | Macrophage migration inhibitory factor is associated with aneurysmal expansion | Q46086580 |
| | The restenosis paradigm revisited: an alternative proposal for cellular mechanisms | Q46465948 |
| | Evidence for a role of macrophage migration inhibitory factor in vascular disease | Q47232432 |
| | Artery size, neointima, and remodeling: time for some standards | Q47274222 |
| | Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. | Q52583321 |
| | Interleukin-18 and macrophage migration inhibitory factor are associated with increased carotid intima-media thickening. | Q53648758 |
| | Comparison of atherosclerotic lesions and HDL-lipid levels in male, female, and testosterone-treated female mice from strains C57BL/6, BALB/c, and C3H. | Q54408751 |
| | Up-regulation and coexpression of MIF and matrix metalloproteinases in human abdominal aortic aneurysms. | Q54647435 |
| | SDF-1α/CXCR4 Axis Is Instrumental in Neointimal Hyperplasia and Recruitment of Smooth Muscle Progenitor Cells | Q56921714 |
| | Macrophage migration inhibitory factor (MIF) and risk for coronary heart disease: Results from the MONICA/KORA Augsburg case-cohort study, 1984–2002 | Q57303220 |
| | Haplotype Effect of the Matrix Metalloproteinase-1 Gene on Risk of Myocardial Infarction | Q57607704 |
| | RANTES (CCL5) uses the proteoglycan CD44 as an auxiliary receptor to mediate cellular activation signals and HIV-1 enhancement | Q58038903 |
| | Crucial Role of the CCL2/CCR2 Axis in Neointimal Hyperplasia After Arterial Injury in Hyperlipidemic Mice Involves Early Monocyte Recruitment and CCL2 Presentation on Platelets | Q61612321 |
| | Reduction of the aortic inflammatory response in spontaneous atherosclerosis by blockade of macrophage migration inhibitory factor (MIF) | Q63915224 |
| | Stabilization of Atherosclerotic Plaques by Blockade of Macrophage Migration Inhibitory Factor After Vascular Injury in Apolipoprotein E–Deficient Mice | Q63915243 |
| | Crucial Role of Stromal Cell–Derived Factor-1α in Neointima Formation After Vascular Injury in Apolipoprotein E–Deficient Mice | Q63915246 |
| | Endogenous p53 Protects Vascular Smooth Muscle Cells From Apoptosis and Reduces Atherosclerosis in ApoE Knockout Mice | Q63915351 |
| | De novo expression of macrophage migration inhibitory factor in atherogenesis in rabbits | Q73281500 |
| | Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis | Q77857409 |
| | Macrophage migration inhibitory factor induces macrophage recruitment via CC chemokine ligand 2 | Q79370205 |
| | Macrophage migration inhibitory factor induces MMP-9 expression: implications for destabilization of human atherosclerotic plaques | Q81109834 |
| | Evidence for vascular macrophage migration inhibitory factor in destabilization of human atherosclerotic plaques | Q81202695 |
| | Right on the spot. Chemokine triggering of integrin-mediated arrest of rolling leukocytes | Q82860945 |
| P433 | issue | 7 | |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 761-770 | |
| P577 | publication date | 2008-04-02 | |
| P1433 | published in | Journal of Molecular Medicine | Q6295593 |
| P1476 | title | Chemokine-like functions of MIF in atherosclerosis | |
| P478 | volume | 86 | |